Komatsu Y, Kubota T, Yasuda T, Takahashi T, Yamamoto A, Kono T, Tabata H, Nohno K, Shibutani T, Umeda M, Yoshie H. Effectiveness of an erbium-doped: yttrium, aluminum and garnet laser for treatment of peri-implant disease: Clinical, microbiological, and biochemical marker analyses. J Clin Exp Dent. 2018;10(10):e970-8.





1. Lindhe J, Meyle J. Peri-implant diseases: consensus report of the sixth European Workshop on Periodontology. J Clin Periodontol. 2008;35:282-5.


2. Savli GE, Cosgarea R, Sculean A. Prevalence and mechanisms of peri-implant diseases. J Dent Res. 2017;96:31-7.


3. Derks J, Tomasi C. Peri-implant health and disease. A systematic review of current epidemiology. J Clin Periodontol. 2015;42:S158-71.


4. Heitz-Mayfield LJA. Peri-implant diseases: diagnosis and risk indicators. J Clin Periodontol. 2008;35:292-304.


5. Kumar PS, Mason MR, Brooker MR, O'Brien K. Pyrosequencing reveals unique microbial signatures associated with healthy and failing dental implants. J Clin Periodontol. 2012;39:425-33.
PMid:22417294 PMCid:PMC3323747


6. Koyanagi T, Sakamoto M, Takeuchi Y, Maruyama N, Ohkuma, M, Izumi Y. Comprehensive microbiological findings in peri-implantitis and periodontitis. J Clin Periodontol. 2013;40:218-26.


7. Murata M, Tatsumi J, Kato Y, Suda S, Nunokawa Y, Kobayashi Y, et al. Osteocalcin, deoxypyridinoline and interleukin-1ß in peri-implant crevicular fluid of patients with peri-implantitis. Clin Oral Implnats Res. 2002;13:637-43.


8. Nomura T, Ishii A, Shimizu H, Taguchi N, Yoshie H, Kusakari H, et al. Tissue inhibitor of metalloproteinases-1, matrix metalloproteinases-1 and -8, and collagenase activity levels in peri-implant crevicular fluid after implantation. Clin Oral Implnats Res. 2000;11:430-40.


9. Duarte PM, Serrão CR, Miranda TS, Zanatta LCS, Bastos MF, Faveri M, et al. Could cytokine levels in the peri-implant crevicular fluid be used to distinguish between healthy implants and implants with peri-implantitis? A systematic review. J Periodont Res. 2016;51:689-98.


10. Dursun E, Tözüm TF. Peri-implant crevicular fluid analysis, enzymes and biomarkers: a systemic review. J Oral Maxillofac Res. 2016;7:e9.
PMid:27833734 PMCid:PMC5100649


11. Karring ES, Stavropoulos A, Ellegaard B, Karring T. Treatment of peri-implantitis by the Vector® system A pilot study. Clin Oral Implants Res. 2005;16:288-93.


12. Renvert S, Samuelsson E, Lindahl C, Persson GR. Mechanical non-surgical treatment of peri-implantitis: a double-blind randomized longitudinal clinical study. I: clinical results. J Clin Periodontol. 2009;36:604-9.


13. Muthukuru M, Zainvi A, Esplugues EO, Flemming TF. Non-surgical therapy for the management of peri-implantitis: a systemic review. Clin Oral Implnats Res. 2012;23:77-83.


14. Yamamoto A, Tanabe T. Treatment of peri-implantitis around TiUite-surface implants using Er: YAG laser microexplosions. Int J Periodontics Restorative Dent. 2013;33:21-9.


15. Yan M, Liu M, Wang M, Yin F, Xia H. The effects of Er: YAG on the treatment of peri-implantitis: a meta-analysis of randomized controlled trials. Lasers Med Sci. 2015;30:1843-53.


16. Shimada Y, Tabeta K, Sugita N, Yoshie, Y. Profiling biomarkers in gingival crevicular fluid using multiplex bead immunoassay. Arch Oral Biol. 2013;58:724-30.


17. Morozumi T, Kubota T, Abe D, Shimizu T, Komatsu Y, Yoshie H. Effects of irrigation with an antiseptic and oral administration of azithromycin on bacteremia caused by scaling and root planning. J Periodontol. 2010;81:1555-63.


18. Sakamoto M, Takeuchi Y, Umeda M, Ishikawa I, Benno Y. Application of terminal RFLP analysis to characterize oral bacterial flora in saliva of healthy subjects and patients with periodontitis. J Med Microbiol. 2003;52:79-89.


19. Hajishengallis G, Lamont RJ. Beyond the red complex and into more complexity: the polymicrobial synergy and dysbiosis (PSD) model of periodontal disease etiology. Mol Oral Microbiol. 2012;27:409-19.
PMid:23134607 PMCid:PMC3653317


20. Valderrama P, Blansett JA, Gonzalez MG, Cantu MG, Wilson TG. Detoxification of Implant surfaces affected by peri-implant disease: an overview of non-surgical methods. Open Dent J. 2014;8:77-84.
PMid:24894571 PMCid:PMC4040927


21. Ando Y, Aoki A, Watanabe H, Ishikawa I. Bactericidal effect of erbium YAG laser on periodontopathic bacteria. Lasers Surg Med. 1996;19:190-200.<190::AID-LSM11>3.0.CO;2-B


22. Birkedal-Hansen H. Role of matrix metalloproteinases in human periodontal diseases. J periodontol. 1993; 64: 474-84.


23. Söder B, Airila Månsson S, Söder PÖ, Kari K, Meurman J. Levels of matrix metalloproteinases-8 and -9 with simultaneous presence of periodontal pathogens in gingival crevicular fluid as well as matrix metalloproteinase-9 and cholesterol in blood. J Periodont Res. 2006;41:411-7.


24. Kubota T, Itagaki M, Hoshino C, Nagata M, Morozumi T, Kobayashi T, et al. Altered gene expression levels of matrix metalloproteinases and their inhibitors in periodontitis-affected gingival tissue. J periodontal. 2008;79:166-73.


25. Salo T, Lyons JG, Rahemtulla F, Birkedal-Hansen H, Larjava H. Transforming growth factor-beta 1 up-regulates type IV collagenase expression in cultured human keratinocytes. J Biol Chem. 1991;266:11436-41.


26. Westerlund U, Ingman T, Lukinmaa PL, Salo T, Kjeldsen L, Borregaard N, et al. Human neutrophil gelatinase and associated lipocalin in adult and localized juvenile periodontitis. J Dent Res. 1996;75:1553-63.


27. Ma J, Kitti U, Hanemaaier R, Teronen OP, Sorsa TA, Natah S, et al. Gelatinase B is associated with peri-implant bone loss. Clin Oral Implants Res. 2003;14:709-13.


28. Özçakır-Tomruk C, Chiquet M, Mericske-Stern R. Tenascin-C and matrix metalloproteinase- 9 levels in crevicular fluid of teeth and implants. Clin Implant Dent and Relat Res. 2012;14:672-81.